Literature DB >> 2305333

Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study.

D Avonts1, M Sercu, P Heyerick, I Vandermeeren, A Meheus, P Piot.   

Abstract

Over a period of 2 years, the authors prospectively followed a cohort of 123 women using an intrauterine device (IUD) and 108 women using oral contraception (OC) in one family practice. They found nine new episodes of cervical chlamydial infection in OC users (7/100 woman years (WY] as compared to 1 new episode in IUD users (0.8/100 WY), yielding a relative risk (RR) for OC users of 8.8 (95% confidence interval (CI): 1.3-59.0). During the 24 months of observation, 15% of OC and 2% of IUD users acquired at least one episode of Chlamydia trachomatis infection (P = .01). Bacterial vaginosis occurred more frequently in IUD users (25/100 WY) than in OC users (9/100 WY) (RR = 2.8; 95% CI: 1.5-5.1). During the 24-month period, 50% of women using an IUD had at least one episode of bacterial vaginosis, compared with 20% of the OC users (P = .001). Symptomatic bacterial vaginosis was associated with the use of an IUD (RR for IUD users was 7.7; 95% CI: 2.1-28.4), whereas asymptomatic bacterial vaginosis was associated with sexual promiscuity.

Entities:  

Keywords:  Belgium; Biology; Chlamydia; Cohort Analysis; Contraception; Contraceptive Methods--side effects; Demographic Factors; Developed Countries; Diseases; Europe; Family Planning; Genital Effects, Female; Genitalia; Genitalia, Female; Incidence; Infections; Iud--side effects; Measurement; Oral Contraceptives--side effects; Physiology; Population; Population Characteristics; Prospective Studies; Reproductive Tract Infections; Research Methodology; Risk Factors; Sexually Transmitted Diseases; Studies; Urogenital System; Western Europe

Mesh:

Substances:

Year:  1990        PMID: 2305333

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

1.  Chlamydia trachomatis and oral contraceptive use: a quantitative review.

Authors:  J Cottingham; D Hunter
Journal:  Genitourin Med       Date:  1992-08

Review 2.  Bacterial vaginosis.

Authors:  C A Spiegel
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  S1-Guideline on Bacterial Vaginosis in Gynecology and Obstetrics: Long version - AWMF Guideline, registration no. 015/028, July 2013 Langfassung - AWMF-Register Nr. 015/028, Juli 2013.

Authors:  W Mendling; J Martius; U B Hoyme
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-01       Impact factor: 2.915

4.  Bacterial vaginosis is not associated with circumcision status of the current male partner.

Authors:  J M Zenilman; A Fresia; B Berger; W M McCormack
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

5.  Risk factors for gonorrhoea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi, Kenya.

Authors:  C C Daly; N Maggwa; J K Mati; M Solomon; S Mbugua; P M Tukei; D J Hunter
Journal:  Genitourin Med       Date:  1994-06

6.  A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

Authors:  Athena P Kourtis; Lisa Haddad; Jennifer Tang; Lameck Chinula; Stacey Hurst; Jeffrey Wiener; Sascha Ellington; Julie A E Nelson; Amanda Corbett; Kristina De Paris; Caroline C King; Mina Hosseinipour; Irving F Hoffman; Denise J Jamieson
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

7.  Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study.

Authors:  Tessa Madden; Jaclyn M Grentzer; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-03       Impact factor: 2.830

Review 8.  Hormonal contraception and HIV-1 transmission.

Authors:  Catherine A Blish; Jared M Baeten
Journal:  Am J Reprod Immunol       Date:  2010-11-19       Impact factor: 3.886

9.  Molecular methodology in determining vaginal flora in health and disease: its time has come.

Authors:  David N Fredricks; Jeanne M Marrazzo
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

Review 10.  Managing recurrent bacterial vaginosis.

Authors:  J Wilson
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.